Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.45 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | PPM1B | O75688 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | RBP4 | P02753 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27464455 | 0.85 | TSHR (0.50) | RAB9ANPC1SMN1; SMN2LOXL2TSHR | |
| SCHEMBL4238470 | 0.82 | MEN1 (0.48) | RAB9ANPC1SMN1; SMN2ALDH1A1PARP1 | |
| SCHEMBL4246223 | 0.82 | PARP1 (0.46) | RAB9ANPC1SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL5423204 | 0.82 | PARP1 (0.49) | RAB9ANPC1GAAALDH1A1PARP1 | |
| SCHEMBL27376943 | 0.81 | SLC2A1 (0.40) | RAB9ANPC1SMN1; SMN2GAAALDH1A1 | |
| SCHEMBL27462508 | 0.81 | PARP1 (0.40) | RAB9ANPC1SMN1; SMN2POLBLMNA | |
| SCHEMBL2282510 | 0.80 | KMO (0.56) | RAB9ASMN1; SMN2TSHRLMNAGAA | |
| SCHEMBL2360322 | 0.80 | NPC1 (0.71) | RAB9ANPC1SMN1; SMN2LOXL2TSHR | |
| SCHEMBL3933287 | 0.79 | KMO (0.54) | RAB9ANPC1LOXL2TSHRCYP4F2 | |
| SCHEMBL6697278 | 0.79 | PARP1 (0.68) | TSHRPOLBPARP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584263-A1 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND USES THEREOF | Chong Kun Dang Pharmaceutical Corp. (KR) | 2025-07-16 | — | — | EP | disclosed |
| CN-119816495-A | 1,3, 4-Oxadiazole derivative compounds as histone deacetylase 6 inhibitors and uses thereof | 株式会社钟根堂 | 2025-04-11 | — | — | CN | disclosed |
| WO-2024054071-A1 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND USES THEREOF | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2024-03-14 | — | — | WO | disclosed |
| EP-3698805-A1 | FRACTION OFZANTHOXYLUM PIPERITUM | Mecox Curemed Co., Ltd. (KR) | 2020-08-26 | — | — | EP | disclosed |
| CN-111574529-A | Muscarinic receptor M3 antagonists and β 2-adrenergic receptor agonist bridged ring derivatives | 四川海思科制药有限公司 | 2020-08-25 | — | — | CN | disclosed |
| WO-2019078386-A1 | FRACTION OF ZANTHOXYLUM PIPERITUM LEAF EXTRACT, EFFECTIVE FOR PAIN RELIEF | 메콕스큐어메드 주식회사 | 2019-04-25 | — | — | WO | disclosed |
| EP-3345904-A1 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | Chiesi Farmaceutici S.p.a. (IT) | 2018-07-11 | — | — | EP | disclosed |
| EP-3345904-A1 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | Chiesi Farmaceutici S.p.a. (IT) | 2018-07-11 | — | — | EP | disclosed |
| EP-2928889-B1 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA (IT) | 2018-03-21 | — | — | EP | disclosed |
| EP-2928889-B1 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA (IT) | 2018-03-21 | — | — | EP | disclosed |
| EP-0469833-B1 | N-Benzyl-Indoles, processes for their preparation and pharmaceutical compositions containing them | LILLY CO ELI (GB) | 1999-09-08 | — | — | EP | disclosed |
| CN-1040108-C | Pharmaceutical compounds | LILLY INDUSTRIES LTD (GB) | 1998-10-07 | — | — | CN | disclosed |
| EP-0399818-B1 | Diarylstyrylquinoline diacids | MERCK FROSST CANADA INC (CA) | 1995-08-16 | — | — | EP | disclosed |
| US-5281593-A | Pharmaceuticals | LILLY INDUSTRIES LIMITED (GB) | 1994-01-25 | — | — | US | disclosed |
| US-5204358-A | Antiallergens; antiinflammatory agents; treatment of asthma, rhinitis, bronchitis and skin diseases | MERCK FROSST CANADA, INC. (CA) | 1993-04-20 | — | — | US | disclosed |
| CN-1061413-A | Medicinal compound | LILLY INDUSTRIES LTD (GB) | 1992-05-27 | — | — | CN | disclosed |
| US-5104882-A | Leukotriene antagonists | MERCK FROSST CANADA, INC. (CA) | 1992-04-14 | — | — | US | disclosed |
| EP-0469833-A1 | N-Benzyl-Indoles, processes for their preparation and pharmaceutical compositions containing them | LILLY INDUSTRIES LIMITED (GB) | 1992-02-05 | — | — | EP | disclosed |
| EP-0399818-A1 | Diarylstyrylquinoline diacids | MERCK FROSST CANADA INC. (CA) | 1990-11-28 | — | — | EP | disclosed |
| EP-0318093-A2 | Diarylquinoline diacids and their use as medicaments | MERCK FROSST CANADA INC. (CA) | 1989-05-31 | — | — | EP | disclosed |